Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
55.75
+1.25 (2.29%)
At close: Jun 4, 2026

Suzhou Ribo Life Science Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Suzhou Ribo Life Science stock has a consensus rating of "Strong Buy" and an average price target of $102.77. The average 1-year stock price forecast is 84.34% higher than the current stock price, while the lowest is $99.04 (+77.65%) and the highest is $109.98 (+97.27%).

Price Target: $102.77 (+84.34%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$99.04$102.77$101.03$109.98
Change+77.65%+84.34%+81.22%+97.27%

Analyst Ratings

The average analyst rating for Suzhou Ribo Life Science stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '26Mar '26Apr '26
Strong Buy244
Buy000
Hold000
Sell000
Strong Sell000
Total244

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Soochow Securities
No rating
Soochow Securities
Buy
Maintains
$115.80
BuyMaintains$115.80+107.71%May 20, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$100.00$90.00
BuyMaintains$100.00$90.00+61.43%Apr 4, 2026
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$102.00
BuyMaintains$102.00+82.96%Mar 30, 2026
Unknown Analyst
Shenwan Hongyuan
No rating
Shenwan Hongyuan
Buy
Maintains
$86.08
BuyMaintains$86.08+54.40%Mar 6, 2026

Financial Forecast

Revenue This Year
162.00M
from 148.51M
Increased by 9.08%
Revenue Next Year
126.24M
from 162.00M
Decreased by -22.07%
EPS This Year
-2.21
from -2.11
EPS Next Year
-2.76
from -2.21
Fiscal YearFY 2018FY 2019FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2018Dec 31, 2019Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--44.00K142.63M148.51M162.00M
Revenue Growth
---324,052.27%4.13%9.08%
Gross Profit
-2.44M-1.96M-24.98M115.65M121.73M147.26M
Gross Margin
---56,777.27%81.09%81.96%90.90%
Operating Income
-111.57M-140.39M-422.49M-258.34M-279.32M-328.66M
Net Income
-98.66M-134.35M-428.35M-270.15M-278.06M-377.95M
EPS
-3.65-4.51-3.34-2.10-2.11-2.21
Free Cash Flow
-80.44M-94.17M--49.05M-119.42M-331.00M
No. Analysts
-----2
Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High190.0M
Avg162.0M
Low134.0M

Revenue Growth

Revenue Growth202620272028
High
27.9%
Avg
9.1%
Low
-9.8%

EPS Forecast

EPS202620272028
High-2.15
Avg-2.21
Low-2.27

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.